Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Considering that most current pharmacological treatments of obesity are linked to major side effects, the preclinical research into 5-amino-1MQ looks promising
Most studies report: No observable toxicity No organ damage No carcinogenic findings in short-term studies However: Long-term human clinical data is limited Most evidence remains preclinical Reference: Sikiric et al., 2018 safety review Summary: BPC-157 Peptide BPC 157 peptides are among the most studied regenerative peptides in experimental research
Sterility Check Ensures the medication is free from bacteria, fungi, and other contaminants
After injecting the water, let the vial rest for 12 minutes
Research Insights NNMT & Obesity Pathways NNMT has been identified as a key regulator of adipose tissue metabolism
AOD9604 vs Intact hGH in Obesity Models A direct head-to-head comparison of AOD9604 and intact hGH in obese and lean mice confirmed that both compounds significantly reduced body weight gain in obese animals through increased fat oxidation and lipolysis stimulation but that AOD9604 achieved this without the hGH receptor binding, IGF-1 stimulation, hyperglycaemia, or reduced insulin secretion associated with full-length hGH treatment
